{"id":3230,"date":"2025-01-28T11:54:12","date_gmt":"2025-01-28T02:54:12","guid":{"rendered":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=3230"},"modified":"2025-01-28T11:54:12","modified_gmt":"2025-01-28T02:54:12","slug":"2020-2","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2020-2\/","title":{"rendered":"2020"},"content":{"rendered":"

2020 (\u8ad6\u6587)<\/h2>\n
    \n
  1. Iikuni S, Watanabe H, Shimizu Y, Nakamoto Y, Ono M.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>PET Imaging and Pharmacological Therapy Targeting Carbonic Anhydrase-IX High-expressing Tumors Using US2 Platform Based on Bivalent Ureidosulfonamide\u00a0<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span><\/span>PLoS One.<\/em>\u00a015(12) e0243327 (2020)<\/span><\/span><\/li>\n
  2. Kaide S, Watanabe H, Shimizu Y, Iikuni S, Nakamoto Y, Hasegawa M, Itoh K, Ono M.<\/span><\/span><\/span><\/span>
    \nIdentification and Evaluation of Bisquinoline Scaffold as a New Candidate for \u03b1-Synuclein-PET Imaging<\/span><\/span><\/span><\/span>
    \nACS Chem. Neurosci. 11(24) 4254-4261 (2020)<\/span><\/span><\/em><\/li>\n
  3. Watanabe H, Kawano K, Iikuni S, Shimizu Y, Ono M.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in\u00a0 pancreas<\/span><\/span><\/span><\/span>
    \n<\/span><\/span><\/span><\/span>Nucl. Med. Biol.<\/em>\u00a090-91 93-97 (2020)<\/span><\/span><\/li>\n
  4. Ubukata S, Oishi N, Higashi T, Kagawa S, Yamauchi H, Okuyama C, Watanabe H, Ono M, Saji H,\u00a0 Aso T, Murai T, Ueda K.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Spatial patterns of amyloid deposition in patients with chronic focal or diffuse traumatic brain injury using 18<\/sup>F-FPYBF-2 PET<\/span><\/span><\/span><\/span>
    \nNeuropsychiatr. Dis. Treat.<\/span><\/span><\/span><\/em>\u00a016 2719-2732 (2020)<\/span><\/span><\/li>\n
  5. Iikuni S, Kitano A, Watanabe H, Shimizu Y, Ono M.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Synthesis and Evaluation of Novel Technetium-99m-hydroxamamide Complex Based on Imidazothiadiazole Sulfonamide Targeting Carbonic Anhydrase-IX for Tumor Imaging<\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em>\u00a030(22) 127596 (2020)<\/span><\/span><\/li>\n
  6. Watanabe H, Sakai S, Iikuni S, Shimizu Y, Shirakawa H, Kaneko S, Ono M.<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Synthesis and Biological Evaluation of Radioiodinated 3-Phenylcoumarin Derivatives Targeting Myelin in Multiple Sclerosis<\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em>\u00a030(24) 127562 (2020)<\/span><\/span><\/li>\n
  7. Fuchigami T, Kawasaki M, Watanabe H, Nakagaki T, Nishi K, Sano K, Atarashi R, Nakaie M, Yoshida S, Ono M, Nishida N, Nakayama M.<\/span><\/span><\/span>\u00a0<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain
    \n<\/span><\/span><\/span><\/span>Nucl. Med. Biol.<\/em>\u00a090-91, 41-48 (2020)<\/span><\/span><\/li>\n
  8. Ding N, Sano K, Kanazaki K, Shimizu Y, Watanabe H, Namita T, Shiina T, Ono M, Saji H.\u00a0<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Development of Gold Nanorods Conjugated with Radiolabeled Anti-human Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody as Single-photon Emission Computed Tomography\/Photoacoustic Dual-imaging Probes Targeting HER2-positive Tumors<\/span><\/span><\/span><\/span>
    \nBiol. Pharm. Bull.<\/em>\u00a043(12) 1859-1866 (2020)<\/span><\/span><\/li>\n
  9. Ding N, Sano K, Kanazaki K, Shimizu Y, Watanabe H, Namita T, Shiina T, Ono M, Saji H.\u00a0<\/span><\/span><\/span>
    \n<\/span><\/span><\/span>Sensitive Photoacoustic\/Magnetic Resonance Dual Imaging Probe for Detection of Malignant Tumors<\/span><\/span><\/span><\/span>
    \nJ. Pharm. Sci.<\/em>\u00a0109(10) 3153-3159 (2020)<\/span><\/span><\/li>\n
  10. Iikuni S, Okada Y, Shimizu Y,\u00a0 Watanabe H, Ono M.
    \n<\/span><\/span><\/span>Synthesis and Evaluation of Indium-111-labeled Imidazothiadiazole Sulfonamide Derivative for Single Photon Emission Computed Tomography Imaging Targeting Carbonic Anhydrase-IX<\/span><\/span><\/span><\/span>
    \nBioorg. Med. Chem. Lett.<\/em>\u00a030(14) 127255 (2020)<\/span><\/span><\/li>\n
  11. Ikeda H, Ishii A, Sano K, Chihara H, Arai D, Abekura Y, Nishi H, Ono M, Saji H, Miyamoto S.<\/span><\/span><\/span>
    \n<\/span>Activatable fluorescence imaging of macrophages in cerebral aneurysms using iron oxide nanoparticles conjugated with indocyanine green<\/span><\/span><\/span><\/span>
    \nFront. Neurosci. <\/em>14 370 (2020)<\/span><\/li>\n
  12. Watanabe H, Kawano K, Shimizu Y, Iikuni S, Nakamoto Y, Togashi K, Ono M.<\/span><\/span><\/span>
    \n<\/span>Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas<\/span><\/span><\/span><\/span>
    \nMol. Pharm.\u00a0<\/em>17(4) 1293-1299 (2020)<\/span><\/li>\n
  13. Watanabe H, Tatsumi H, Kaide S, Shimizu Y, Iikuni S, Ono M.<\/span>
    \n<\/span>Structure-activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes<\/span><\/span><\/span>
    \nACS Med. Chem. Lett. <\/em>11(2) 120-126 (2020)<\/span><\/li>\n
  14. Kawai R, Chiba S, Okuwaki K, Kanada R, Doi H, Ono M, Mochizuki Y, Okuno Y.<\/span>
    \n<\/span>Stabilization Mechanism for a Non-fibrillar Amyloid \u03b2 Oligomer Based on Formation of a Hydrophobic Core Determined by Dissipative Particle Dynamics<\/span><\/span><\/span>
    \nACS Chem. Neurosci.\u00a0<\/em>11(3) 385-394 (2020)<\/span><\/li>\n<\/ol>\n

    \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

    2020 (\u8457\u66f8\u7b49)<\/h2>\n
      \n
    1. \u98ef\u570b \u614e\u5e73, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
      \n<\/span><\/span><\/span><\/span>\u70ad\u9178\u8131\u6c34\u9175\u7d20-IX \u9ad8\u767a\u73fe\u816b\u760d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f99m<\/sup>Tc-\u30d2\u30c9\u30ed\u30ad\u30b5\u30e0\u30a2\u30df\u30c9\u932f\u4f53\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span>
      \nJSMI Report<\/em> 13(1) 27-31 (2020)<\/li>\n<\/ol>\n

      \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n

      2020 (\u5b66\u4f1a\u767a\u8868)<\/h2>\n
        \n
      1. \u4e2d\u5cf6 \u4e00\u78e8, \u98ef\u570b \u614e\u5e73, \u5ca1\u7530 \u7950\u54c9, \u6e21\u908a \u88d5\u4e4b, \u5fd7\u6c34 \u967d\u4e00, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u70ad\u9178\u8131\u6c34\u7d20\u9175\u7d20IX\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u898f68<\/sup>Ga\u6a19\u8b58\u5316\u5408\u7269\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c60\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u795e\u6238\uff09 2020\u5e7411\u670812\u65e5\u301c14\u65e5<\/span><\/span><\/span><\/li>\n
      2. \u9234\u6728\u7530 \u4e07\u91cc, \u5fd7\u6c34 \u967d\u4e00, \u5b50\u5b89 \u7fd4, \u9032\u85e4 \u5cb3\u90ce, \u5c0f\u91ce \u6b63\u535a, \u4e2d\u672c \u88d5\u58eb<\/span><\/span><\/span>
        \n<\/span>CCR4\u6a19\u7684\u6cbb\u7642\u85ac”Mogamulizumab”\u306e\u751f\u4f53\u5185\u5206\u5e03\u306e\u89e3\u660e\u3092\u76ee\u7684\u3068\u3057\u305fSPECT\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5264\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c60\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u795e\u6238\uff09 2020\u5e7411\u670812\u65e5\u301c14\u65e5<\/span><\/span><\/span><\/li>\n
      3. \u5b89\u85e4 \u6b63\u767b, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>99m<\/sup>Tc\u6a19\u8b582\u4fa1\u30ea\u30ac\u30f3\u30c9\u3092\u5bb9\u6613\u306b\u8abf\u6574\u53ef\u80fd\u3068\u3059\u308bHydroxamamide\u6bcd\u6838\u4e8c\u5b98\u80fd\u6027\u30ad\u30ec\u30fc\u30c8\u5264\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c60\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u795e\u6238\uff09 2020\u5e7411\u670812\u65e5\u301c14\u65e5<\/span><\/span><\/span><\/li>\n
      4. \u6e21\u908a \u88d5\u4e4b, \u5de6\u6d77 \u6c50\u68a8, \u5fd7\u6c34 \u967d\u4e00, \u98ef\u570b \u614e\u5e73, \u767d\u5ddd \u4e45\u5fd7, \u91d1\u5b50 \u5468\u53f8, \u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span>
        \n<\/span>\u591a\u767a\u6027\u786c\u5316\u75c7\u306e\u753b\u50cf\u8a3a\u65ad\u3092\u76ee\u7684\u3068\u3057\u305f\u30df\u30a8\u30ea\u30f3\u6a19\u7684SPECT\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
        \n\u7b2c60\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u795e\u6238\uff09 2020\u5e7411\u670812\u65e5\u301c14\u65e5<\/span><\/span><\/span><\/span><\/li>\n
      5. \u8c9d\u51fa \u7fd4,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u9577\u8c37\u5ddd \u6210\u4eba,\u00a0<\/span>\u4f0a\u6771 \u606d\u5b50,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u03b1\u30b7\u30cc\u30af\u30ec\u30a4\u30f3\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u30d3\u30b9\u30ad\u30ce\u30ea\u30f3\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u304a\u3088\u3073\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      6. \u4e95\u5e8a \u6709\u5e0c,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u30aa\u30ec\u30ad\u30b7\u30f31\u53d7\u5bb9\u4f53\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f18<\/sup>F\u6a19\u8b58\u30d9\u30f3\u30be\u30d5\u30e9\u30f3\u304a\u3088\u3073\u30ad\u30ce\u30ea\u30f3\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      7. \u5ca1\u7530 \u7950\u54c9,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u814e\u96c6\u7a4d\u4f4e\u6e1b\u3092\u76ee\u6307\u3057\u305f\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u3092\u6a19\u7684\u3068\u3059\u308b\u653e\u5c04\u6027\u91d1\u5c5e\u932f\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      8. \u5cb8\u672c \u5cfb\u660e,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u8fb0\u5df3 \u60a0\u83ef,\u00a0<\/span>\u8c9d\u51fa \u7fd4,\u00a0<\/span>\u5782\u6c34 \u52c7\u592a,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u3092\u6a19\u7684\u3068\u3059\u308bSPECT\u7528\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a\u3092\u76ee\u7684\u3068\u3057\u305f125<\/sup>I\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30df\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u69cb\u9020\u6d3b\u6027\u52d5\u614b\u76f8\u95a2\u7814\u7a76<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      9. \u524d\u5ddd \u9234\u9999,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u677e\u5c3e \u51ea\u7d17,\u00a0<\/span>\u767d\u5ddd \u4e45\u5fd7,\u00a0<\/span>\u91d1\u5b50 \u5468\u53f8,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u591a\u767a\u6027\u786c\u5316\u75c7\u306e\u8a3a\u65ad\u3092\u76ee\u7684\u3068\u3057\u305f\u30df\u30a8\u30ea\u30f3\u6a19\u7684\u6838\u533b\u5b66\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      10. \u5317\u91ce \u674f\u5948,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u30b9\u30eb\u30db\u30f3\u30a2\u30df\u30c9\u9aa8\u683c\u3092\u5c0e\u5165\u3057\u305f\u65b0\u898f99m<\/sup>Tc-\u30d2\u30c9\u30ed\u30ad\u30b5\u30e0\u30a2\u30df\u30c9\u932f\u4f53\u306e\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u3068\u3057\u3066\u306e\u6709\u7528\u6027\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      11. \u4e2d\u5cf6 \u4e00\u78e8,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5ca1\u7530 \u7950\u54c9,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u70ad\u9178\u8131\u6c34\u9175\u7d20IX\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u653e\u5c04\u6027\u30ac\u30ea\u30a6\u30e0\u6a19\u8b58\u30a4\u30df\u30c0\u30be\u30c1\u30a2\u30b8\u30a2\u30be\u30fc\u30eb\u30b9\u30eb\u30db\u30f3\u30a2\u30df\u30c9\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u57fa\u790e\u7684\u8a55\u4fa1<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n
      12. \u4e95\u51fa \u5353\u5fd7,\u00a0<\/span>\u6e21\u908a \u88d5\u4e4b,\u00a0<\/span>\u8c9d\u51fa \u7fd4,\u00a0<\/span>\u98ef\u570b \u614e\u5e73,\u00a0<\/span>\u5fd7\u6c34 \u967d\u4e00,\u00a0<\/span>\u9577\u8c37\u5ddd \u6210\u4eba,\u00a0<\/span>\u4f0a\u6771 \u606d\u5b50,\u00a0<\/span>\u5c0f\u91ce \u6b63\u535a<\/span><\/span><\/span><\/span><\/span>
        \n\u30ec\u30d3\u30fc\u5c0f\u4f53\u75c5\u306b\u304a\u3051\u308b\u03b1\u30b7\u30cc\u30af\u30ec\u30a4\u30f3\u51dd\u96c6\u4f53\u3092\u6a19\u7684\u3068\u3057\u305f\u86cd\u5149\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span><\/span><\/span><\/span><\/span>
        \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c140\u5e74\u4f1a (\u4eac\u90fd) 2020\u5e743\u670826\u65e5\u301c28\u65e5<\/span><\/span><\/span><\/li>\n<\/ol>\n

        \u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\u623b\u308b<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

        2020 (\u8ad6\u6587) Iikuni S, Watanabe H, Shimizu Y, Nakamoto Y, Ono M. PET Imaging and Pharmacological Therapy Targetin […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-3230","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/3230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=3230"}],"version-history":[{"count":1,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/3230\/revisions"}],"predecessor-version":[{"id":3231,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/3230\/revisions\/3231"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=3230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}